B V Batotsyrenov Selected Research

B V Batotsyrenov Research Topics

22	Poisoning 01/2020 - 07/2001
8	Disease Progression 01/2018 - 01/2011
7	Hypoxia (Hypoxemia) 01/2018 - 01/2010
6	Coma (Comas) 01/2020 - 01/2010
3	Brain Diseases (Brain Disorder) 01/2013 - 11/2011
3	Delirium 01/2013 - 01/2012
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 03/2002
2	Alcohol Withdrawal Delirium (Delirium Tremens) 01/2016 - 01/2012
1	Brain Edema (Cerebral Edema) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Respiratory Acidosis 01/2020
1	Lactic Acidosis 01/2020
1	Hyperammonemia 01/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Hyperlactatemia 01/2016
1	Alcoholic Fatty Liver 01/2016
1	Alcoholism (Alcohol Abuse) 01/2015
1	Acidosis 01/2013
1	Binge Drinking 04/2012
1	Lead Poisoning (Poisoning, Lead) 03/2012
1	Peritonitis 01/2011
1	Heart Failure 05/2010
1	Myocardial Infarction 05/2010
1	Critical Illness (Critically Ill) 11/2005
1	Wounds and Injuries (Trauma) 03/2002

9	ReamberinIBA 01/2018 - 01/2010
7	Ethanol (Ethyl Alcohol)IBA 01/2020 - 07/2001
6	cytoflavinIBA 01/2020 - 01/2010
5	RemaxolIBA 01/2016 - 01/2012
5	Free RadicalsIBA 01/2015 - 07/2001
4	Oxygen (Dioxygen)IBA 01/2015 - 03/2002
4	PoisonsIBA 01/2013 - 11/2005
3	AntioxidantsIBA 01/2016 - 05/2010
2	AcidsIBA 01/2020 - 01/2018
2	Carbon MonoxideIBA 01/2013 - 01/2012
2	S-Adenosylmethionine (Ademetionine)IBA 01/2013 - 04/2012
2	Antidepressive Agents (Antidepressants)IBA 03/2002 - 07/2001
2	Antipsychotic Agents (Antipsychotics)IBA 03/2002 - 07/2001
1	Carbon DioxideIBA 01/2020
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2020
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2018
1	barbituric acid (barbiturate)IBA 01/2018
1	AlbuminsIBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	Methanol (Carbinol)IBA 01/2013
1	AntidotesIBA 01/2013
1	AlkaliesIBA 01/2013
1	Methadone (Dolophine)FDA LinkGeneric 03/2012
1	Lipid PeroxidesIBA 03/2012
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2012
1	Opiate AlkaloidsIBA 11/2011
1	SolutionsIBA 03/2002
1	Narcotics (Narcotic Analgesics)IBA 03/2002
1	Surface-Active Agents (Surfactants)IBA 03/2002
1	Succinic Acid (Succinate)IBA 07/2001

15	Therapeutics 01/2020 - 07/2001
4	Duration of Therapy 01/2016 - 01/2012
3	Critical Care (Surgical Intensive Care) 01/2016 - 07/2001
2	Resuscitation 04/2012 - 01/2012
1	Renal Dialysis (Hemodialysis) 01/2013
1	Intravenous Administration 01/2013
1	Length of Stay 11/2011